Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Antmed is a China-based medical device company focused on the R&D, manufacturing, sales, and service of high-tech products used in medical imaging, cardiovascular intervention, peripheral minimally invasive surgery, anesthesia and intensive care, and dental care. The company is best known for contrast media injectors, high-pressure syringes, injection tubing systems, disposable pressure transducers, and interventional accessories such as inflation devices and hemostasis valves. Antmed emphasizes in-house vertical integration across R&D, tooling, component manufacturing, assembly, sterilization, and after-sales support, which it positions as a differentiator in contrast delivery systems. Its products are marketed globally in more than 120-130 countries and regions, and the company has built a broad commercial footprint across Asia, Europe, the Americas, Africa, and Oceania. Antmed appears to be a commercial-stage medtech manufacturer rather than a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Antmed.